a decision‐making algorithm for the management of pregnancy in the inflammatory bowel disease patient

FM Habal, VW Huang - Alimentary pharmacology & …, 2012 - Wiley Online Library
Background Inflammatory bowel disease affects patients who are in their reproductive years.
There are many questions regarding the management of IBD patients who are considering …

Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome.

…, KN Jeejeebhoy, JP Baker, JP Allard, FM Habal… - Gut, 1994 - gut.bmj.com
Elemental diets are considered an effective primary treatment for active Crohn's disease.
This study examined the hypothesis that improvement occurs because of the presence of …

[HTML][HTML] From conception to delivery: managing the pregnant inflammatory bowel disease patient

VW Huang, FM Habal - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) typically affects patients during their adolescent and
young adult years. As these are the reproductive years, patients and physicians often have …

Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course

FM Habal, G Hui, GR Greenberg - Gastroenterology, 1993 - Elsevier
Background: Oral 5-aminosalicylic acid (5-ASA) has proven an effective maintenance therapy
of ulcerative colitis and may also be useful in Crohn's disease, but its safety in pregnancy …

[HTML][HTML] Management of inflammatory bowel disease in the pregnant patient

FM Habal, NC Ravindran - World Journal of Gastroenterology …, 2008 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a chronic disorder affecting young adults in their
reproductive years. Many young women with IBD express concern about the effect their disease …

Safety of topical 5-aminosalicylic acid in pregnancy.

CM Bell, FM Habal - American Journal of Gastroenterology …, 1997 - search.ebscohost.com
Objective: To assess the safety and efficacy of topical 5-aminosalicylic acid preparations for
therapy of distal colitis during pregnancy. Methods: Nineteen pregnancies in sixteen …

Isolation of two functionally different kininogens from human plasma—separation from proteinase inhibitors and interaction with plasma kallikrein

FM Habal, HZ Movat, CE Burrowes - Biochemical Pharmacology, 1974 - Elsevier
A high (HMW) and a low (LMW) molecular weight kininogen were isolated in highly purified
form from human plasma, using QAE-Sephadex chromatography, followed by ammonium …

The inhibition of human plasma kallikrein by antithrombin III

CE Burrowes, FM Habal, HZ Movat - Thrombosis Research, 1975 - Elsevier
Prekallikrein, prekallikrein activator, high molecular weight kininogen and antithrombin III were
isolated from human plasma. The prekallikrein was converted to kallikrein by prekallikrein …

Inflammatory bowel disease and pregnancy: evidence, uncertainty and patient decision-making

FM Habal, V Kapila - Canadian Journal of Gastroenterology and …, 2009 - hindawi.com
Inflammatory bowel disease (IBD) often affects women during their child-bearing years.
Management of a pregnant IBD patient, or a patient contemplating pregnancy, poses unique …

The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors

JYC Chan, CE Burrowes, FM Habal… - … and biophysical research …, 1977 - Elsevier
Human factor XII was activated by adsorption onto kaolin in the presence of high molecular
weight kininogen. The washed kaolin-containing precipitates activate prekallikrein to …